HealthMore in Health→
USC team reports renewable cell source for macrophage cancer therapies
Key Takeaways
- USC-led researchers reported a way to extensively expand granulocyte-monocyte progenitors in the lab.
- The progenitor cells can be engineered to target cancer markers and support broader immune responses.
- The work suggests a scalable starting point for macrophage-based, potentially off-the-shelf cell therapies.
DE
DT Editorial Team··via medicalxpress.com
